Galectin Therapeutics (GALT) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 257.29% |
| Dec 31, 2025 | -60.84% |
| Sep 30, 2025 | -0.40% |
| Jun 30, 2025 | 6.84% |
| Mar 31, 2025 | -57.65% |
| Dec 31, 2024 | 114.56% |
| Sep 30, 2024 | -30.22% |
| Jun 30, 2024 | 22.19% |
| Mar 31, 2024 | 49.14% |
| Dec 31, 2023 | -30.89% |
| Sep 30, 2023 | 13.57% |
| Jun 30, 2023 | -22.05% |
| Mar 31, 2023 | -2.79% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 5.26% |
| Jun 30, 2022 | -24.59% |
| Mar 31, 2022 | 31.19% |
| Dec 31, 2021 | 11.41% |
| Sep 30, 2021 | 1.03% |
| Jun 30, 2021 | 1,560.00% |
| Mar 31, 2021 | -93.83% |
| Dec 31, 2020 | 38.97% |
| Sep 30, 2020 | 3.55% |
| Jun 30, 2020 | -8.37% |
| Mar 31, 2020 | 3.86% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | -6.55% |
| Jun 30, 2019 | 7.52% |
| Mar 31, 2019 | -90.71% |
| Dec 31, 2018 | 443,300.00% |
| Sep 30, 2018 | -99.93% |
| Jun 30, 2018 | 20,514.29% |
| Mar 31, 2018 | 16.67% |
| Dec 31, 2017 | -97.39% |
| Sep 30, 2017 | -14.50% |
| Jun 30, 2017 | 1,821.43% |
| Mar 31, 2017 | -97.07% |
| Dec 31, 2016 | 27.13% |
| Sep 30, 2016 | -6.47% |
| Jun 30, 2016 | -67.13% |
| Mar 31, 2016 | 1,622.54% |
| Dec 31, 2015 | -91.05% |
| Sep 30, 2015 | -0.88% |
| Jun 30, 2015 | -14.44% |
| Mar 31, 2015 | 17.02% |
| Dec 31, 2014 | -8.89% |
| Sep 30, 2014 | 17.72% |
| Jun 30, 2014 | 2,880.00% |
| Mar 31, 2014 | -95.13% |
| Dec 31, 2013 | -71.63% |
| Sep 30, 2013 | 945.09% |
| Jun 30, 2013 | -79.69% |
| Mar 31, 2013 | 36.98% |
| Dec 31, 2012 | -24.05% |
| Sep 30, 2012 | -6.83% |
| Jun 30, 2012 | 85.84% |
| Mar 31, 2012 | 118.35% |
| Dec 31, 2011 | -497.23% |
| Sep 30, 2011 | -51.13% |
| Jun 30, 2011 | 86.78% |
| Mar 31, 2011 | 149.34% |
| Dec 31, 2010 | -456.68% |